The Ripatti group studies genetics of common complex diseases from discovery to translation to health care. We utilize Finnish research cohorts and a global network of biobank data with longitudinal ...

Revealing the molecular mechanisms underlying common complex diseases holds the promise of improved and targeted prediction, prevention, diagnosis and treatment. Building on unique resources and an ...

leaving a lasting legacy in the fight against complex diseases. The firm's name, Legacy, is deeply symbolic, reflecting the founders' personal histories and aspirations for the future. The two ...